StockData
Revelation Biosciences, Inc. logo

Revelation Biosciences, Inc. (REVB) stock

REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.88+0.06 (+1.57%)

Close on Nov 17, 2026Market cap $15.46MP/E –Yield –

Revelation Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Revelation Biosciences

Revelation Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Revelation Biosciences figures

See a number that looks wrong?